The Big Pharma has teamed up with Ashley Tisdale to discuss the actor-singer-entrepreneur’s experience with alopecia areata, an autoimmune disease that typically causes sudden bouts of hair loss in patches on the head and face.
Pfizer poaches Novartis exec for oncology commercial chief post
Merck`s Capvaxive gears up to challenge Pfizer`s dominant Prevnar with CDC panel backing
An antibody-drug conjugate patent arbitration fight that Seagen waged against Daiichi Sankyo has officially ended in a win for the Japanese company.
RSV vaccine makers’ shares fall as CDC adjusts shot guidance
NEW YORK, June 26 (Reuters) - Moderna Inc (MRNA.O), opens new tab respiratory syncytial virus (RSV) shot mRESVIA showed 50% efficacy in preventing RSV after 18 months, the drugmaker said on Wednesday. nIn their clinical trials, GSK's RSV vaccine Arexvy was 78% effective in preventing severe RSV over a second year and Pfizer's was 78% effective through a second RSV season.
Pfizer Declares Third-Quarter 2024 Dividend
UK selects Pfizer over GSK to supply RSV vaccines for 2 years
Alnylam touts `big-win scenario` for closely watched heart trial
Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts